drugset / Trial / NCT01071499

Pharmacokinetics of Oral Morphine and Pharmacogenomics of CYP2D6 and UGT2B7, in an Urban Pediatric Population Presenting for Elective Surgery

NCT01071499

Phase 2/3 Completed 43 enrolled University of British Columbia
RandomizedParallel-groupOpen-labelOther

Summary

The purpose of this study is to identify and collect samples from children who have taken a single oral dose of the pain medication morphine, and to determine the genetic differences in the way children metabolize (break down in the body and how it affects them) morphine.

Timeline

Start
2010-03
Primary completion
2012-11
Completion
2012-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Morphine Other / unclassified 0.1 mg/kg Oral
Comparator Morphine Other / unclassified 0.2 mg/kg Oral
Comparator Morphine Other / unclassified 0.3 mg/kg Oral

Indications

No indication recorded.